𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients

✍ Scribed by Frank, O; Brors, B; Fabarius, A; Li, L; Haak, M; Merk, S; Schwindel, U; Zheng, C; Müller, M C; Gretz, N

Book ID
110056788
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
277 KB
Volume
20
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O36 Factors of imatinib resistance in ch
O36 Factors of imatinib resistance in chronic myeloid leukemia
✍ B. Kajtár; D. Alpár; J. Tóth; R. László; P. Jáksó; L. Kereskai; Z. Nagy; L. Pajo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Hb-Hana family is the first described example, where partial glutathione reductase deficiency represents a modifying factor of clinical manifestation of unstable hemoglobinopathy. Grant support: MSM 6198959205 and MSM 6198959216. O35 A prognostic impact of transfusion dependency on survival of pati

Effects of carboxyamidotriazole on in vi
Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia
✍ Riccardo Alessandro; Simona Fontana; Margherita Giordano; Chiara Corrado; Paolo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

## Abstract Although imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML), some patients develop resistance with progression of leukemia. Alternative or additional targeting of signaling pathways deregulated in bcr‐abl‐driven CML cells may provide a feasible opt